Modeling the kinetics of the permeation of antibacterial agents into growing bacteria and its interplay with efflux

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 10, 2017, Pages

  Nichols, Wright W ^a  

^a Independent Researcher   (United States)

Author keywords

Antibacterial drug discovery; Bacterial permeability; Efflux

Indexed keywords

ANTIINFECTIVE AGENT; CEFALORIDINE; CEFALOTIN; CEFAMANDOLE; CHLORAMPHENICOL; NITROCEFIN; CARRIER PROTEIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; CELL DIVISION; CELL GROWTH; CELL MEMBRANE PERMEABILITY; DILUTION; DRUG PENETRATION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KINETICS; MATHEMATICAL MODEL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CELL MEMBRANE; CELL WALL; DRUG DEVELOPMENT; DRUG EFFECT; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; THEORETICAL MODEL; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL WALL; DRUG DISCOVERY; ESCHERICHIA COLI; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MODELS, THEORETICAL;

EID: 85029741873     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02576-16     Document Type: Article

References (75)

1. Buurman ET, Laganas VA, Liu CF, Manchester JL. 2012. Antimicrobial activity of adenine-based inhibitors of NAD+-dependent DNA ligase. Med Chem Lett 3:663–667. https://doi.org/10.1021/ml300169x.
2. Nichols WW. 2012. Permeability of bacteria to antibacterial agents, p 849–879. In Dougherty TJ, Pucci MJ (ed), Antibiotic discovery and development, vol II. Springer Publishing Company, New York, NY.
3. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656. https://doi.org/10.1128/MMBR.67.4.593-656.2003.
4. Collander R. 1954. The permeability of Nitella cells to non-electrolytes. Physiol Plant 7:420–445. https://doi.org/10.1111/j.1399-3054.1954.tb07589.x.
5. Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G. 1998. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. Eur J Pharm Sci 6:313–319.
6. Nikaido H, Thanassi DG. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoro-quinolones as examples. Antimicrob Agents Chemother 37:1393–1399. https://doi.org/10.1128/AAC.37.7.1393.
7. Sigler A, Schubert P, Hillen W, Niederweis M. 2000. Permeation of tetracyclines through membranes of liposomes and Escherichia coli. Eur J Biochem 277:527–534.
8. Palmer M. 2003. Efflux of cytoplasmically acting antibiotics from Gram-negative bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their cooperative action with single-component transporters. J Bacteriol 185:5287–5289. https://doi.org/10.1128/JB.185.17.5287-5289.2003.
9. Nikaido H, Pagès JM. 2012. Broad specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340–363. https://doi.org/10.1111/j.1574-6976.2011.00290.x.
10. Redish EF. 2016. Analysing the competency of mathematical modelling in physics. Cornell University Library, Ithaca, NY. https://arxiv.org/abs/1604.02966. Accessed 18 February 2017.
11. Cha PD, Rosenberg JJ, Dym CL. 2000. Fundamentals of modeling and analysing engineering systems, p 1–11. In Fundamental concepts in mathematical modeling. Cambridge University Press, Cambridge, United Kingdom.
12. Tempest DW. 1978. Dynamics of bacterial growth. In Norris JR, Richmond MH (ed), Essays in microbiology. John Wiley & Sons, Chichester, United Kingdom.
13. Nichols WW, Evans MJ, Slack MPE, Walmsley HL. 1989. Diffusion of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol 135:1291–1303.
14. Stewart PS. 2003. Diffusion in biofilms. J Bacteriol 185:1485–1491. https://doi.org/10.1128/JB.185.5.1485-1491.2003.
15. Vesselinova N, Alexandrov BS, Wall ME. 2016. Dynamical model of drug accumulation in bacteria: sensitivity analysis and experimentally testable predictions. PLoS One 11:e0165899. https://doi.org/10.1371/journal.pone.0165899.
16. The Pew Charitable Trusts. 2016. A scientific roadmap for antibiotic discovery. The Pew Charitable Trusts, Philadelphia, PA. http://www.pewtrusts.org/antibiotic-discovery. Accessed 26 February 2017.
17. Basarab GS, Eakin AE, Nichols WW. 2014. Design of antibacterial agents, p 611– 626. In Tang Y-W, Sussman M, Liu D, Poxton I, Schwartzman J (ed), Molecular medical microbiology, 2nd ed. Academic Press, New York, NY.
18. Tommasi R, Brown DG, Walkup GK, Manchester JI, Miller AA. 2015. ESKAPEing the labyrinth of antibacterial discovery. Nat Rev Drug Discov 14:529–542. https://doi.org/10.1038/nrd4572.
19. Lieb WR, Stein WD. 1986. Simple diffusion across the membrane bilayer, p 69–112. In Stein WD (ed), Transport and diffusion across cell membranes. Academic Press, New York, NY.
20. Zimmermann W, Rosselet A. 1977. Function of the outer membrane of Escherichia coli as a permeability barrier to -lactam antibiotics. Antimicrob Agents Chemother 12:368 –372. https://doi.org/10.1128/AAC.12.3.368.
21. Snyder DS, McIntosh TJ. 2000. The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe kinetics. Biochemistry 39:11777–11787. https://doi.org/10.1021/bi000810n.
22. Hill AV. 1928. The diffusion of oxygen and lactic acid through tissues. Proc R Soc B 104:39–96. https://doi.org/10.1098/rspb.1928.0064.
23. Brodin B, Steffansen B, Nielsen CU. 2010. Passive diffusion of drug substances: the concepts of flux and permeability, p 135–152. In Steffansen B, Brodin B, Nielsen CU (ed), Molecular biopharmaceutics. Pharmaceutical Press, London, United Kingdom.
24. International Organization for Standardization. 2006. Clinical laboratory testing and in vitro diagnostic test systems—susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 1. Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. ISO 20776-1:2006. International Organization for Standardization, Geneva, Switzerland.
25. Demchick P, Koch AL. 1996. The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. J Bacteriol 178:768 –773. https://doi.org/10.1128/jb.178.3.768-773.1996.
26. Stein WD. 1986. Thermodynamics and kinetics of the diffusion process, p 35–46. In Stein WD (ed), Transport and diffusion across cell membranes. Academic Press, New York, NY.
27. Kreysig E. 1983. Advanced engineering mathematics, p 28–29. John Wiley & Sons, Inc, New York, NY.
28. Gualtieri M, Banéres-Roquet F, Villain-Guillot P, Pugnière M, Leonetti J-P. 2009. The antibiotics in the chemical space. Curr Med Chem 16:390 –393. https://doi.org/10.2174/092986709787002628.
29. Macielag MJ. 2012 Chemical properties of antimicrobials and their uniqueness, p 793–820. In Dougherty TJ, Pucci MJ (ed), Antibiotic drug discovery and development, vol II. Springer Publishing Company, New York, NY.
30. O’Shea R, Moser HE. 2008. Physichochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem 51:2871–2878. https://doi.org/10.1021/jm700967e.
31. Lomovskaya O, Watkins W. 2001. Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699–1711. https://doi.org/10.2174/0929867013371743.
32. Nagano K, Nikaido H. 2009. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A 106:5854–5858. https://doi.org/10.1073/pnas.0901695106.
33. Lim SP, Nikaido H. 2010. Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother 54:1800–1806. https://doi.org/10.1128/AAC.01714-09.
34. Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P. 2008. The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol 22:633–648. https://doi.org/10.1111/j.1472-8206.2008.00633.x.
35. Nikaido H. 2005. Restoring permeability barrier function to outer membrane. Chem Biol 12:507–509.
36. Li X-Z, Plésiat P, Nikaido H. 2015. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 28: 337–418. https://doi.org/10.1128/CMR.00117-14.
37. Lee A, Mao W, Warren MS, Mistry A, Hoshino K, Okumura R, Ishida H, Lomovskaya O. 2000. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 182:3142–3150. https://doi.org/10.1128/JB.182.11.3142-3150.2000.
38. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322–3327. https://doi.org/10.1128/AAC.44.12.3322-3327.2000.
39. Manchester JI, Buurman ET, Bisacchi GS, McLaughlin RE. 2012. Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery. J Med Chem 55:2532–2537. https://doi.org/10.1021/jm201275d.
40. Nichols WW. 1988. Towards a fundamental understanding of the MIC of -lactam antibiotics. J Antimicrob Chemother 22:275–283. https://doi.org/10.1093/jac/22.3.275.
41. Lakaye B, Dubus A, Lepage S, Groslambert S, Frère JM. 1999. When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with -lactams. Mol Microbiol 31:89–101. https://doi.org/10.1046/j.1365-2958.1999.01150.x.
42. Kojima S, Nikaido H. 2013. Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci U S A 110:E2629–E2634. https://doi.org/10.1073/pnas.1310333110.
43. Welling PG, Craig WA, Bundtzen RW, Kwok FW, Gerber AU, Madsen PO. 1983. Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother 23:881– 887. https://doi.org/10.1128/AAC.23.6.881.
44. Stein WD. 1997. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77:545–590.
45. Hewinson RG, Lane DC, Slack MPE, Nichols WW. 1986. The permeability parameter of the outer membrane of Pseudomonas aeruginosa varies with the concentration of a test substrate, cephalosporin C. J Gen Microbiol 132:27–33.
46. James CE, Mahendran KR, Molitor A, Bolla JM, Bessonov AN, Winterhalter M, Pagès JM. 2009. How -lactam antibiotics enter bacteria: a dialogue with the porins. PLoS One 4:e5453. https://doi.org/10.1371/journal.pone.0005453.
47. Nichols WW. 1987. The time course of hydrolysis of a -lactam antibiotic by intact Gram-negative bacteria possessing a periplasmic -lactamase. Biochem J 244:509–513. https://doi.org/10.1042/bj2440509.
48. Benz R, Schmid A, Vos-Scheperkeuter GH. 1987. Mechanism of sugar transport through the sugar-specific LamB channel of Escherichia coli outer membrane. J Membr Biol 100:21–29. https://doi.org/10.1007/BF02209137.
49. Buyck J, Luyckx C, Muccioli G, Krause K, Nichols WW, Tulkens P, Van Bambeke F. 2017. Pharmacodynamics of ceftazidime-avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa. J Antimicrob Chemother 72:1400–1409. https://doi.org/10.1093/jac/dkw587.
50. Lebeaux D, Ghigo JM, Beloin C. 2014. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543. https://doi.org/10.1128/MMBR.00013-14.
51. Grant SS, Hung DT. 2013. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 4:273–283. https://doi.org/10.4161/viru.23987.
52. Krulwich TA, Sachs G, Padan E. 2011. Molecular aspects of bacterial pH sensing and homeostasis. Nat Rev Microbiol 9:330–343. https://doi.org/10.1038/nrmicro2549.
53. Stock JB, Rauch B, Roseman S. 1977. Periplasmic space in Salmonella typhimurium and Escherichia coli. J Biol Chem 252:7850–7861.
54. Nichols WW, Hewinson RG, Slack MPE, Walmsley HL. 1985. Estimation of the permeability parameter (C) for the flux of a charged molecule across the Gram-negative outer membrane. Biochem Soc Trans 13:697–698. https://doi.org/10.1042/bst0130697.
55. Sen K, Hellman J, Nikaido H. 1988. Porin channels in intact cells of Escherichia coli are not affected by Donnan potentials across the outer membrane. J Biol Chem 263:1182–1187.
56. Epand RM, Epand RF. 2009. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788:289–294. https://doi.org/10.1016/j.bbamem.2008.08.023.
57. Delcour AH. 2009. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808–816. https://doi.org/10.1016/j.bbapap.2008.11.005.
58. Borovinskaya MA, Pai RD, Zhang W, Schuwirth BS, Holton JM, Hirokawa G, Kaji H, Kaji A, Cate JH. 2007. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat Struct Mol Biol 14: 727–732. https://doi.org/10.1038/nsmb1271.
59. Bednarska NG, Schymkowitz J, Rousseau F, Van Eldere J. 2013. Protein aggregation in bacteria: the thin boundary between functionality and toxicity. Microbiology 159:1795–1806. https://doi.org/10.1099/mic.0.069575-0.
60. Taber HW, Mueller JP, Miller PF, Arrow AS. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51:439–457.
61. Scholar EM, Pratt WB. 2000. Bactericidal inhibitors of protein synthesis. The aminoglycosides, p 127–158. In Scholar EM, Pratt WB (ed), The antimicrobial drugs, 2nd ed. Oxford University Press, Oxford, United Kingdom.
62. Zhang G, Meredith TC, Kahne D. 2013. On the essentiality of lipopolysaccharide to Gram-negative bacteria. Curr Opin Microbiol 16:779–785. https://doi.org/10.1016/j.mib.2013.09.007.
63. May JM, Sherman DJ, Simpson BW, Ruiz N, Kahne D. 2015. Lipopolysac-charide transport to the cell surface: periplasmic transport and assembly into the outer membrane. Philos Trans R Soc Lond B Biol Sci 370: 20150027. https://doi.org/10.1098/rstb.2015.0027.
64. Livermore DM. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634–640. https://doi.org/10.1086/338782.
65. Goldman RC, Capobianco JO. 1990. Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 34:1973–1980. https://doi.org/10.1128/AAC.34.10.1973.
66. Beveridge TJ. 2000. Ultrastructure of Gram-positive cell walls, p 3–11. In Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (ed), Gram-positive pathogens. ASM Press, Washington DC.
67. Sundararaj S, Guo A, Habibi-Nazhad B, Rouani M, Stothard P, Ellison M, Wishart DS. 2004. The CyberCell Database (CCDB): a comprehensive, self-updating, relational database to coordinate and facilitate in silico modeling of Escherichia coli. Nucleic Acids Res 32(Database issue):D293–D295.
68. Smit J, Kamio Y, Nikaido H. 1975. Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J Bacteriol 124:942–958.
69. Kashket ER. 1981. Effects of aerobiosis and nitrogen source on the proton motive force in growing Escherichia coli and Klebsiella pneu-moniae cells. J Bacteriol 146:377–384.
70. Duncan JL, Cho GJ. 1971. Production of staphylococcal alpha toxin. I. Relationship between cell growth and toxin formation. Infect Immun 4:456–461.
71. Xiang T-X, Anderson BD. 1994. The relationship between permeant size and permeability in lipid bilayer membranes. J Membr Biol 140:111–122.
72. Bean RC, Shepherd WC, Chan H. 1968. Permeability of lipid bilayer membranes to organic solutes. J Gen Physiol 52:495–508. https://doi.org/10.1085/jgp.52.3.495.
73. Chakrabarti AC, Deamer DW. 1992. Permeability of lipid bilayers to amino acids and phosphate. Biochim Biophys Acta 1111:171–177. https://doi.org/10.1016/0005-2736(92)90308-9.
74. Deamer DW, Bramhall J. 1986. Permeability of lipid bilayers to water and ionic solutes. Chem Phys Lipids 40:167–188. https://doi.org/10.1016/0009-3084(86)90069-1.
75. Hauser H, Oldani D, Phillips MC. 1973. Mechanism of ion escape from phosphatidylcholine and phosphatidylserine single bilayer vesicles. Biochemistry 12:4507–4517.